Home Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy
Article
Licensed
Unlicensed Requires Authentication

Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy

  • Christian Pina EMAIL logo , Ahmed Khattab , Philip Katzman , Lauren Bruckner , Jeffrey Andolina , Maria New and Mabel Yau EMAIL logo
Published/Copyright: November 26, 2014

Abstract

A 14-year-old female with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency underwent bilateral adrenalectomy at 6 years of age as a result of poor hormonal control. Because the patient was adrenalectomized, extra adrenal androgen production was suspected. Imaging studies including pelvic ultrasound and pelvic magnetic resonance imaging (MRI) were obtained to evaluate for adrenal rest tumors of the ovaries. Abdominal MRI was obtained to evaluate for residual adrenal tissue. A cystic lesion arising from her right ovary suspicious for ovarian neoplasm was noted on pelvic MRI. Right salpingo-oophorectomy was performed and histopathological examination revealed ovarian serous adenocarcinoma, low-grade, and well-differentiated. Tumor marker CA-125 was elevated and additional ovarian cancer staging workup confirmed stage IIIC due to one lymph node positive for carcinoma. The patient then developed a large left ovarian cyst, which led to a complete total abdominal hysterectomy and removal of the left ovary and fallopian tube. Pathology confirmed ovarian serous adenocarcinoma with microscopic focus of carcinoma in the left ovary. After numerous complications, the patient responded well to chemotherapy, CA-125 levels fell and no evidence of carcinoma was observed on subsequent imaging. To our knowledge, this is the first reported case of an ovarian serous adenocarcinoma in a patient with CAH. Although rare, we propose that the ovaries were the origin of androgen production and not residual adrenal tissue. The relationship between CAH and ovarian carcinomas has yet to be established, but further evaluation is needed given the poor survival rate of high-grade serous ovarian carcinoma.


Corresponding authors: Christian E. Pina and Mabel Yau, Division of Adrenal Steroid Disorders, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA, Phone: +1-212-241-7847, E-mail: ,

References

1. New MI, Lekarev O, Mancenido D, Parsa A, Yuen T. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. In: New MI, Lekarev O, Parsa A, Yuen T, O’Malley BW, Hammer GD, editors. Genetic steroid disorders. London, UK: Elsevier, 2014: 29–51.Search in Google Scholar

2. Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866–74.Search in Google Scholar

3. New MI, Abraham M, Gonzalez B, Dumic M, Razzaghy-Azar M, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci USA 2013;110:2611–6.10.1073/pnas.1300057110Search in Google Scholar

4. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Genet 1985;37:650–67.Search in Google Scholar

5. Haider S, Islam B, D’Atri V, Sgobba M, Poojari C, et al. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci USA 2013;110:2605–10.10.1073/pnas.1221133110Search in Google Scholar

6. Zhang M, Jiang W, Li G, Xu C. Ovarian masses in children and adolescents – an analysis of 521 clinical cases. J Pediatr Adolesc Gynecol 2014;27:e73–7.10.1016/j.jpag.2013.07.007Search in Google Scholar

7. Fernández-García Salazar R, Muñoz-Darias C, Jesús Haro Mora J, Almaraz MC, Audí L, et al. Woman with virilizing congenital adrenal hyperplasia and leydig cell tumor of the ovary. Gynecol Endocrinol 2014;30:549–52.10.3109/09513590.2014.907260Search in Google Scholar

8. Kamata Y, Hayashi A, Ogawa A, Ichikawa R, Moriya T, et al. A woman with salt-wasting congenital adrenal hyperplasia presenting with a mucinous ovarian cystadenoma during pregnancy. Intern Med 2011;50:1981–5.10.2169/internalmedicine.50.5401Search in Google Scholar

9. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, et al. CA 125: the past and the future. Int J Biol Markers 1998;13:179–87.10.1177/172460089801300402Search in Google Scholar

10. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 2006;98:1694–706.10.1093/jnci/djj465Search in Google Scholar

11. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117–30.10.1086/375033Search in Google Scholar

12. Katsumata N, Yasuda M, Takahashi F, Isonishi S, Jobo T, et al. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet 2009;374:1331–8.10.1016/S0140-6736(09)61157-0Search in Google Scholar

13. Crocker MK, Barak S, Millo CM, Beall SA, Niyyati M, et al. Use of PET/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2012;97:E2084–9.10.1210/jc.2012-2298Search in Google Scholar PubMed PubMed Central

14. Martinez-Aguayo A, Rocha A, Rojas N, García C, Parra R, et al. Testicular adrenal rest tumor and Leydig and Sertoli cell function in boys with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007;92:4583–9.10.1210/jc.2007-0383Search in Google Scholar

15. Stikkelbroeck NM, Hermus AR, Schouten D, Suliman HM, Jager GJ, et al. Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging. 2004;14:1802–6.10.1007/s00330-004-2329-xSearch in Google Scholar

16. Russo G, Paesano P, Taccagni G, Del Maschio A, Chiumello G. Ovarian adrenal-like tissue in congenital adrenal hyperplasia. N Engl J Med 1998;339:853–4.10.1056/NEJM199809173391220Search in Google Scholar

17. Luton JP, Clerc J, Paoli V, Bonnin A, Dumez Y, et al. Bilateral Leydig cell tumor of the ovary in a woman with congenital adrenal hyperplasia. The first reported case. Presse Med 1991;20:109–12.Search in Google Scholar

18. Tiosano D, Vlodavsky E, Filmar S, Weiner Z, Goldsher D, et al. Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy. Horm Res Paediatr 2010;74:223–8.10.1159/000295722Search in Google Scholar

19. Zaarour MG, Atallah DM, Trak-Smayra VE, Halaby GH. Bilateral ovary adrenal rest tumor in a congenital adrenal hyperplasia following adrenalectomy. Endocr Pract 2014;20:e69–74.10.4158/EP13092.CRSearch in Google Scholar

20. Motlik K, Zuntoya A. Gonocytoma – disgerminoma and gonadoblastoma. (Ovarian neoplasms in children and adolescents)]. Cesk Patol 1973;9:14–23.Search in Google Scholar

21. Güran T, Yeşil G, Güran Ö, Cesur S, Bosnalı O, et al. A giant ovarian cyst in a neonate with classical 21-hydroxylase deficiency with very high testosterone levels demonstrating a high-dose hook effect. J Clin Res Pediatr Endocrinol 2012;4:151–3.10.4274/Jcrpe.685Search in Google Scholar

22. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:4133–60.10.1210/jc.2009-2631Search in Google Scholar

23. SEER cancer statistics review, 1975–2004. In: Reis LA, Melbert D, Krapcho M, et al., editors. Bethesda, MD: National Cancer Institute, 2007.Search in Google Scholar

24. Suzuki T, Ino K, Kikkawa F, Shibata K, Kajiyama H, et al. Cushing’s syndrome due to ovarian serous adenocarcinoma secreting multiple endocrine substances: a case report and immunohistochemical analysis. Gynecol Oncol 2003;90: 662–6.10.1016/S0090-8258(03)00407-4Search in Google Scholar

25. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774–86.10.1093/jnci/90.23.1774Search in Google Scholar PubMed

26. Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. J Am Med Assoc 1995;274:1926–30.10.1001/jama.1995.03530240036037Search in Google Scholar

27. Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, et al. Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer 2003;104:636–42.10.1002/ijc.10990Search in Google Scholar PubMed

28. Rinaldi S, Dossus L, Lukanova A, Peeters PH, Allen NE, et al. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2007;16:23–9.10.1158/1055-9965.EPI-06-0755Search in Google Scholar PubMed

29. Tworoger SS, Lee IM, Buring JE, Hankinson SE. Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 2008;167:211–8.10.1093/aje/kwm278Search in Google Scholar PubMed

30. Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, et al. Epithelial ovarian cancer: testing the ‘androgens hypothesis’. Endocr Relat Cancer 2008;15:1061–8.10.1677/ERC-08-0075Search in Google Scholar PubMed

31. Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 2007;43:690–709.10.1016/j.ejca.2006.11.010Search in Google Scholar PubMed

32. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.10.3322/caac.20107Search in Google Scholar PubMed

33. Li J, Fadare O, Xiang L, Kong B, Zheng W. Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol 2012;5:8.10.1186/1756-8722-5-8Search in Google Scholar PubMed PubMed Central

Received: 2014-6-3
Accepted: 2014-9-26
Published Online: 2014-11-26
Published in Print: 2015-5-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Obesity
  3. Childhood obesity at the crossroads
  4. Obesogenic environments: environmental approaches to obesity prevention
  5. Childhood obesity and eating behaviour
  6. Hypothalamic obesity in children: pathophysiology to clinical management
  7. The reliability of body mass index in the diagnosis of obesity and metabolic risk in children
  8. Determining abdominal obesity cut-offs and relevant risk factors for anthropometric indices in Turkish children and adolescents
  9. The effect of body mass index on blood pressure varies by race among obese children
  10. Insulin secretion response during oral glucose tolerance test is related to low cardiorespiratory fitness in obese adolescents
  11. Is there a relationship between cardiovascular risk factors and dehydroepiandrosterone sulfate levels in childhood obesity?
  12. The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children
  13. Childhood obesity, thyroid function, and insulin resistance – is there a link? A longitudinal study
  14. Associations between IGF-I, IGF-binding proteins and bone turnover markers in prepubertal obese children
  15. Osteocalcin is inversely associated with adiposity and leptin in adolescent boys
  16. Association between cardiovascular risk factors and carotid intima-media thickness in prepubertal Brazilian children
  17. Insulin resistance and cardiometabolic risk factors in obese children and adolescents: a hierarchical approach
  18. The role of apolipoprotein E polymorphism in improving dyslipidemia in obese adolescents following physical exercise and National Cholesterol Education Program Step II intervention
  19. Review article
  20. Is ultrasound useful in the diagnosis of adolescents with polycystic ovary syndrome?
  21. Original articles
  22. IGF-II expression and methylation in small for gestational age infants
  23. Early screening of FTO and MC4R variants in newborns of Greek origin
  24. Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency
  25. The prevalence of vitamin D deficiency among schoolchildren: a cohort study from Xinxiang, China
  26. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?
  27. Vitamin D status and its associations with components of metabolic syndrome in healthy children
  28. Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome
  29. Patient reports
  30. Hypothyroidism caused by the combination of two heterozygous mutations: one in the TSH receptor gene the other in the DUOX2 gene
  31. Ovarian carcinoma in a 14-year-old with classical salt-wasting congenital adrenal hyperplasia and bilateral adrenalectomy
  32. An asymptomatic mother diagnosed with 3-methylcrotonyl-CoA carboxylase deficiency after newborn screening
  33. A new missense mutation in the BCKDHB gene causes the classic form of maple syrup urine disease (MSUD)
  34. Ovotesticular disorder of sex development with unusual karyotype: patient report
  35. First case report of medium-chain acyl-coenzyme A dehydrogenase deficiency in China
  36. Virilizing adrenal oncocytoma in a 9-year-old girl: rare neoplasm with an intriguing postoperative course
  37. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency
  38. Sirolimus therapy in a patient with severe hyperinsulinaemic hypoglycaemia due to a compound heterozygous ABCC8 gene mutation
  39. Cross-reactivity of adrenal steroids with aldosterone may prevent the accurate diagnosis of congenital adrenal hyperplasia
  40. Hyperthyroidism hidden by congenital central hypoventilation syndrome
  41. The use of pamidronate for acute vitamin D intoxication, clinical experience with three cases
  42. Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis
  43. Cushing syndrome related to leukemic infiltration of the central nervous system
  44. Hashimoto’s encephalopathy: a rare pediatric brain disease
  45. Short communication
  46. A novel ABCD1 gene mutation in a Chinese patient with X-linked adrenoleukodystrophy
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0299/html
Scroll to top button